All in the head: obstacles for immune rejection of brain tumours. - Wikidata - wikimedia - TriplyDB

All in the head: obstacles for immune rejection of brain tumours.

All in the head: obstacles for immune rejection of brain tumours.

http://www.wikidata.org/entity/Q34842204

about

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma Focused ultrasound-aided immunomodulation in glioblastoma multiforme: a therapeutic concept.Function of PD-L1 in antitumor immunity of glioma cells.Mechanisms of malignant glioma immune resistance and sources of immunosuppression Immunotherapy of brain cancers: the past, the present, and future directions.Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications.Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling.Immunotherapeutic approaches for glioma Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.Impact of Human Immunodeficiency Virus in the Pathogenesis and Outcome of Patients with Glioblastoma Multiforme.Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Transforming growth factor-beta and its implication in the malignancy of gliomas.Immunological Aspects of Malignant Gliomas.Atopy and risk of brain tumors: a meta-analysis.History of allergies and risk of glioma in adults.Targeting brain metastases in patients with melanoma.Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO).Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.

P2860

Q24615166-2D37FD85-F417-4F92-B08A-6F2DF024C874 Q26774997-D8ED7662-81CB-45E0-84BA-D821E752C7A3 Q33632655-D107CD92-CB53-4D63-A920-A13A0BE0548B Q34661793-58D157D1-4E47-4546-8AA9-694B0B60AAE2 Q34701587-238C9B71-79B2-4B35-8C3E-4DCD3CBAF635 Q35499988-C94ED05D-8AF6-4A5D-9438-F74E285B3867 Q36118290-58526941-9277-4C96-89BC-A1338E114869 Q36641509-480603B3-9ECC-4E15-B755-E2AAD21F4C68 Q36695932-46A51C77-B103-48B8-A272-2A4E06F3C750 Q36978377-2F770C48-2880-4385-8792-1FCE2D7A4A65 Q37267793-3473DC0D-68BE-451C-B02D-A702D99908E9 Q37344951-B61B6895-F572-4D53-8F84-3A7F3A9DC93B Q37421034-CBACB23A-6F66-4DB8-856D-DC2E5A51B2C5 Q37608106-E0E835D5-054B-404D-9A92-AFD21FF30411 Q37735454-9E16A27A-4A25-48E8-90C3-62235F7E30BF Q38192972-FF2CF685-77E2-45D5-8B88-9FDEAC926EEA Q38870994-E211F0D4-8823-4066-A97D-F0659F8F88D1 Q40437316-79933EF4-11E5-408E-A6B3-AD90F79DA42A Q40475089-E51D2F97-8B69-47EA-BA7D-33746316B6FB Q41858635-836DE573-78A2-42DE-B0D9-AC1A3F79F068 Q45278583-E2613B67-2D4E-4AD3-85B9-7A76E3EC3406 Q49093554-837BB8EC-E051-4DBA-AFDD-ACEC7A9188F4

P2860

All in the head: obstacles for immune rejection of brain tumours.

http://www.wikidata.org/entity/Q34842204

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

All in the head: obstacles for immune rejection of brain tumours.

@ast

All in the head: obstacles for immune rejection of brain tumours.

@en

All in the head: obstacles for immune rejection of brain tumours.

@nl

type

label

All in the head: obstacles for immune rejection of brain tumours.

@ast

All in the head: obstacles for immune rejection of brain tumours.

@en

All in the head: obstacles for immune rejection of brain tumours.

@nl

prefLabel

All in the head: obstacles for immune rejection of brain tumours.

@ast

All in the head: obstacles for immune rejection of brain tumours.

@en

All in the head: obstacles for immune rejection of brain tumours.

@nl

P1433

Q34842204-9FAB9987-62A5-4433-8C2A-3A138A287C0C

P1476

Q34842204-0793C78D-CDE8-4A78-AD58-5A01F39DD5C3

P2093

Q34842204-4BA47E46-F532-408F-9D9F-FC363C2EEA27

Q34842204-5F20AF32-005E-4DBC-9440-F883A5851F6E

Q34842204-C6683D8A-F363-4FF5-8CFC-EAF43BFAC1AF

P2860

Q34842204-00722F8D-2277-49A9-8EE4-F2E6832138EC

Q34842204-0265B2D1-940E-4532-B3C6-6CB2570CB03E

Q34842204-0525C4CF-9238-45A3-84A0-17EB7C7CF32D

Q34842204-09660946-F326-4004-9648-56CF1323FEDF

Q34842204-0A87CD44-CAAE-45E1-8913-DDAAB3FCCE04

Q34842204-0ED8FBFF-CCD2-4DAF-9615-80D38F1F672C

Q34842204-118A392D-B7F1-43A3-AFC6-5461E793D20C

Q34842204-189DF6E3-15D4-454C-A47D-ECE36C52CE09

Q34842204-1DE451D9-177F-4596-B7DF-2BCC08111458

Q34842204-1F3521F5-6C98-4846-B20C-8E8DD0B2DE40

P304

Q34842204-D29DC583-6B77-4597-BE14-AAA1739ACD2A

P31

Q34842204-7B9C906A-4021-47B6-9458-14937FEA3A84

P356

Q34842204-3EFC2935-1C5B-494E-9FBC-3EA0BC5C1988

P433

Q34842204-D97A726F-5163-43FB-A813-10815640DE75

P478

Q34842204-E5B54586-0063-437A-83AF-398CA176A885

P577

Q34842204-E2C52DCD-BFB3-40B6-B5AC-B46FE6715782

P5875

Q34842204-70115664-F6C7-43FC-B7FF-AD7715B5A95A

P698

Q34842204-C3E4F00B-999E-4216-A69F-A3FD81BE8A1C

P932

Q34842204-0351CBF6-529E-4C9B-8DA6-517898BC2137

P356

J.1365-2567.2002.01507.X

P1433

P1476

All in the head: obstacles for immune rejection of brain tumours.

@en

P2093

Paul R Walker

http://www.w3.org/2001/XMLSchema#string

Pierre-Yves Dietrich

http://www.w3.org/2001/XMLSchema#string

Thomas Calzascia

http://www.w3.org/2001/XMLSchema#string

P2860

CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

Junctions between intimately apposed cell membranes in the vertebrate brain

The Fas death factor

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Functions of nonclassical MHC and non-MHC-encoded class I molecules.

The cell biology of the blood-brain barrier.

Leukocyte traffic in the central nervous system: the participants and their roles.

Gene transfer of Fas ligand induces tumor regression in vivo.

P304

28-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2567.2002.01507.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11164968

http://www.w3.org/2001/XMLSchema#string

P698

12225360

http://www.w3.org/2001/XMLSchema#string

P932

1782770

http://www.w3.org/2001/XMLSchema#string